Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Hypoxia activated pro-drug TH-302 induces hypoxia-dependent anti-leukemia activity in vitro and in vivo
While compounded medications may involve additional considerations compared to FDA-approved products, they may offer alternative formulation or dosing options when deemed appropriate by a prescribing provider
Animals don't even wear clothing
For reference, tirzepatide costs approximately $1,060 CAD monthly in the United States without insurance, while semaglutide runs around $1,350 CAD monthly
FDA approves first oral GLP-1 treatment for type 2 diabetes B
US$ 29.62
US$ 26.23
US$ 25.91
US$ 25.36
